Key Financial Inc Raises Stock Holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Key Financial Inc boosted its stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 52.2% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 1,166 shares of the exchange traded fund’s stock after buying an additional 400 shares during the period. Key Financial Inc’s holdings in SPDR S&P Biotech ETF were worth $105,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Golden State Wealth Management LLC acquired a new position in SPDR S&P Biotech ETF in the 4th quarter valued at about $29,000. Avior Wealth Management LLC grew its position in SPDR S&P Biotech ETF by 393.6% in the 4th quarter. Avior Wealth Management LLC now owns 385 shares of the exchange traded fund’s stock valued at $35,000 after acquiring an additional 307 shares in the last quarter. Tidemark LLC grew its position in SPDR S&P Biotech ETF by 101.5% in the 3rd quarter. Tidemark LLC now owns 395 shares of the exchange traded fund’s stock valued at $39,000 after acquiring an additional 199 shares in the last quarter. Quintet Private Bank Europe S.A. acquired a new position in SPDR S&P Biotech ETF in the 3rd quarter valued at about $40,000. Finally, Howe & Rusling Inc. acquired a new position in SPDR S&P Biotech ETF in the 3rd quarter valued at about $49,000.

SPDR S&P Biotech ETF Price Performance

NYSEARCA XBI opened at $91.33 on Wednesday. The company has a market cap of $6.96 billion, a P/E ratio of 11.47 and a beta of 1.11. The stock has a 50-day moving average of $91.51 and a two-hundred day moving average of $96.03. SPDR S&P Biotech ETF has a 1-year low of $81.14 and a 1-year high of $105.47.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.